The association of body composition parameters and adverse events in women receiving chemotherapy for early breast cancer

被引:0
|
作者
G. F. P. Aleixo
S. S. Shachar
A. M. Deal
K. A. Nyrop
H. B. Muss
Y. T. Chen
H. Yu
G. R. Williams
机构
[1] University of North Carolina at Chapel Hill,Division of Hematology
[2] Universidade Do Oeste Paulista (UNOESTE),Oncology
[3] Ruth and Bruce Rappaport Faculty of Medicine at Technion,Lineberger Comprehensive Cancer Center
[4] University of North Carolina at Chapel Hill,Division of Radiology
[5] University of North Carolina at Chapel Hill,Division of Hematology/Oncology
[6] The University of Alabama at Birmingham,undefined
来源
关键词
Breast cancer; Myosteatosis; Chemotherapy outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:631 / 642
页数:11
相关论文
共 50 条
  • [31] Body composition and chemotherapy toxicity in women with early breast cancer (CANDO-3): protocol for an observational cohort study
    Durkin, Kesta
    Heetun, Adam
    Ewings, Sean
    Munday, Richard
    Wootton, Stephen A.
    Turner, Lesley
    Copson, Ellen R.
    Cutress, Ramsey, I
    BMJ OPEN, 2022, 12 (02):
  • [32] The Relationship Between Body Composition and Response to Neoadjuvant Chemotherapy in Women with Operable Breast Cancer
    Del Fabbro, Egidio
    Parsons, Henrique
    Warneke, Carla L.
    Pulivarthi, Kalyan
    Litton, Jennifer K.
    Dev, Rony
    Palla, Shana L.
    Brewster, Abenaa
    Bruera, Eduardo
    ONCOLOGIST, 2012, 17 (10): : 1240 - 1245
  • [33] Association between Concomitant Use of Hydrochlorothiazide and Adverse Chemotherapy-Related Events among Older Women with Breast Cancer Treated with Cyclophosphamide
    Hsu, Christine D.
    Hinton, Sharon Peacock
    Reeder-Hayes, Katherine E.
    Sanoff, Hanna K.
    Lund, Jennifer L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (02) : 520 - 523
  • [34] Patterns of body composition and muscle strength in women during chemotherapy for breast cancer.
    Visovsky, Constance
    Seo, Yaewon
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 181 - 182
  • [35] Body composition and chemotherapy toxicity among women treated for breast cancer: a systematic review
    Wopat, Heather
    Harrod, Tom
    Brem, Rachel F. F.
    Kaltman, Rebecca
    Anderson, Kendall
    Robien, Kim
    JOURNAL OF CANCER SURVIVORSHIP, 2024, 18 (04) : 1356 - 1369
  • [36] Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer
    Freedman, RJ
    Aziz, N
    Albanes, D
    Hartman, T
    Danforth, D
    Hill, S
    Sebring, N
    Reynolds, JC
    Yanovski, JA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (05): : 2248 - 2253
  • [37] Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer
    Freedman, R
    Aziz, N
    Hartman, T
    Albanes, D
    Danforth, D
    Hill, S
    Sebring, N
    Yanovski, J
    OBESITY RESEARCH, 2003, 11 : A107 - A107
  • [38] Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
    Maaike M. G. A. van den Berg
    Dieuwertje E. Kok
    Liesbeth Posthuma
    Lisette Kamps
    Celine S. Kelfkens
    Nicole Buist
    Maud Geenen
    Annebeth Haringhuizen
    Joan B. Heijns
    Rianne H. M. A. van Lieshout
    Maartje Los
    Dirkje W. Sommeijer
    Johanna N. H. Timmer-Bonte
    Anja Th. C. M. de Kruif
    Hanneke W. M. van Laarhoven
    Ellen Kampman
    Renate M. Winkels
    Breast Cancer Research and Treatment, 2019, 173 : 475 - 481
  • [39] Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer
    Mariano, Caroline
    Lund, Jennifer L.
    Hinton, Sharon Peacock
    Htoo, Phyo
    Muss, Hyman
    Reeder-Hayes, Katherine E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (04) : 242 - 248
  • [40] Racial disparities in symptom burden among women receiving early stage breast cancer chemotherapy
    Nasrollahi, Elham
    Abujaradeh, Hiba
    Mazanec, Susan
    O'Brien, Julia
    Schlemmer, Isabelle M.
    Rosenzweig, Margaret
    CANCER RESEARCH, 2024, 84 (06)